Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores

Liver Transplantation

Volumn 12, Issue 4, 2006, Pages 614-620

  Xia, Victor W ^a   Du, Bin ^a,b   Braunfeld, Michelle ^a   Neelakanta, Gundappa ^a   Hu, Ke Qin ^c   Nourmand, Hamid ^a   Levin, Philip ^a   Enriquez, Ronald ^a   Hiatt, Jonathan R ^a   Ghobrial, R Mark ^a   Farmer, Douglas G ^a   Busuttil, Ronald W ^a   Steadman, Randolph H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOCAPROIC ACID; APROTININ; FIBRINOGEN; INSULIN; NORADRENALIN; PHENYLEPHRINE; POTASSIUM ION; TRANEXAMIC ACID;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMATOCRIT; HEPATITIS B; HEPATITIS C; HUMAN; HYPERKALEMIA; INTRAOPERATIVE PERIOD; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BLOOD TRANSFUSION; COMORBIDITY; FEMALE; HEALTH PRIORITIES; HUMANS; INTRAOPERATIVE CARE; LIVER DISEASES; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; REPERFUSION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 33645549055     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20679     Document Type: Article

References (21)

1. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-871.
2. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001:33: 464-470.
3. Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A, Lucey MR. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 2004:40:897-903.
4. Sheth M, Riggs M, Patel T. Utility of the Mayo end-stage liver disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002;2:2.
5. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005;41:353-358.
6. Wiesner RH, McDiarmid SV, Kamath PS, Edwards EB, Malinchoc M, Kremers WK, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001;7:567-580.
7. Kanwal F, Dulai GS, Spiegel BM, Yee HF, Gralnek IM. A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther 2005;21: 169-177.
8. Freeman, RB Jr. MELD/PELD: One year later. Transplant Proc 2003;35:2425-2427.
9. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, Yersiz H, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003;9:473-476.
10. Onaca NN, Levy MF, Netto GJ, Thomas MJ, Sanchez EQ, Chinnakotla S, et al. Pretransplant MELD score as a predictor of outcome after liver transplantation for chronic hepatitis C. Am. J Transplant 2003;3:626-630.
11. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:117-123.
12. Roberts MS. Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl 2004;10:886-897.
13. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004:77:99-106.
14. Kremers WK, van Ijperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-769.
15. Narayanan Menon KV, Nyberg SL, Harmsen WS, DeSouza NF, Rosen CB, Krom RA, Wiesner RH. MELD and other factors associated with survival after liver transplantation. Am J Transplant 2004;4:819-825.
16. Cacciarelli TV, Keeffe EB, Moore DH, Burns W, Busque S, Concepcion W. et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Arch Surg 1999;134:25-29.
17. Massicotte L, Sassine MP, Lenis S, Roy A. Transfusion predictors in liver transplant. Anesth Analg 2004;98: 1245-1251.
18. Findlay JY, Rettke SR. Poor prediction of blood transfusion requirements in adult liver transplantations from preoperative variables. J Clin Anesth 2000;12:319-323.
19. Frasco PE. Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: Relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg 2005;101:30-37.
20. Trotter JF, Osgood MJ. MELD scores of liver transplant recipients according to size of waiting list: Impact of organ allocation and patient outcomes. JAMA 2004;291:1871-1874.
21. Mehrabi A, Golling M, Kashfi A, Boucsein T, Schemmer P, Gutt CN, et al. Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation. Liver Transpl 2005;11:174-187.